U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


Indonesia Files Genocide Case Against Myanmar's Min Aung Hlaing Over Rohingya Crisis
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Trump Eyes Cabinet Shake-Up Amid Iran War Political Fallout
U.S.-Iran War Escalates: Downed Fighter Jet, Stalled Ceasefire Talks, and Ground Invasion Fears
Army Chief of Staff Gen. Randy George Forced Into Immediate Retirement Amid U.S.-Iran War
Britain Courts Anthropic Amid US Defense Department Dispute
Cuba Announces Release of Over 2,000 Prisoners in Second Amnesty of 2025
Kim Jong Un's Daughter Emerges as North Korea's Likely Successor, South Korean Intelligence Says
Federal Judge Rules CBP Violated Warrantless Arrest Order During Sacramento Immigration Sweep
U.S. Envoys Witkoff and Kushner Expected to Visit Kyiv in April Amid Stalled Peace Talks
Ukraine Launches Massive Drone Offensive Across Russia, Knocking Out Power to Hundreds of Thousands
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
US Military Eyes 10,000 Troop Surge to Middle East Amid Iran Nuclear Tensions
California Renames Cesar Chavez Day to Farmworkers Day Following Sexual Abuse Allegations
Australia's Energy Crisis: Free Public Transport as Fuel Shortages Bite
U.S. Returns Chinese Drug Suspect to China in Landmark Extradition 



